Measurement of charm production in neutrino charged-current interactions

The nuclear emulsion target of the CHORUS detector was exposed to the wide-band neutrino beam of the CERN SPS of 27 GeV average neutrino energy from 1994 to 1997. In total about 100000 charged-current neutrino interactions with at least one identified muon were located in the emulsion target and fully reconstructed, using newly developed automated scanning systems. Charmed particles were searched for by a program recognizing particle decays. The observation of the decay in nuclear emulsion makes it possible to select a sample with very low background and minimal kinematical bias. 2013 charged-current interactions with a charmed hadron candidate in the final state were selected and confirmed through visual inspection. The charm production rate induced by neutrinos relative to the charged-current cross-section is measured to be sigma(nu_mu N -> mu- C X)/sigma(CC) = (5.75 +-0.32 stat +-0.30 syst)%. The charm production cross-section as a function of the neutrino energy is also obtained. The results are in good agreement with previous measurements. The charm-quark hadronization produces the following charmed hadrons with relative fractions (in %): f_Dzero = 43.7+-4.5, f_Lambda_c^plus = 19.2+-4.2, f_Dplus = 25.3+-4.2, and f_D_splus = 11.8+-4.7.Comment: 16 pages, 5 figure

Retroperitoneal fibrosis: a case report

Retroperitoneal fibrosis is characterized by development of extensive fibrosis, leading to entrapment and obstruction of retroperitoneal structures, notably the ureters. In most cases, the etiology is unknown. It is occasionally associated with autoimmune diseases. Response to corticosteroids and immunosuppressive therapy suggest it is probably immunologically mediated. The symptoms and signs associated with retroperitoneal fibrosis are non-specific, and diagnosis requires a high degree of suspicion. We should always have in mind retroperitoneal fibrosis in differential diagnosis of hydronephrosis

Performances of a resistive Micromegas module for the Time Projection Chambers of the T2K Near Detector upgrade

International audienceAn upgrade of the Near Detector of the T2K long baseline neutrino oscillation experiment, ND280, has been proposed. This upgrade will include two new Time Projection Chambers, each equipped with 16 resistive Micromegas modules for gas amplification. A first prototype of resistive Micromegas has been designed, built, installed in the HARP field cage, and exposed to a beam of charged particles at CERN. The data have been used to characterize the performances of the resistive Micromegas module. A spatial resolution of 300 μm and a deposited energy resolution of 9% were observed for horizontal electrons crossing the TPCs at 30 cm from the anode. Such performances fully satisfy the requirements for the upgrade of the ND280 TPC

Genotypic and phenotypic spectrum of infantile liver failure due to pathogenic TRMU variants.

Purpose: The study aimed to define the genotypic and phenotypic spectrum of reversible acute liver failure (ALF) of infancy resulting from biallelic pathogenic TRMU variants and to determine the role of cysteine supplementation in its treatment. Methods: Individuals with biallelic (likely) pathogenic variants in TRMU were studied through an international retrospective collection of de-identified patient data. Results: In 62 individuals, including 30 previously unreported cases, we described 48 (likely) pathogenic TRMU variants, of which, 18 were novel. Of these 62 individuals, 42 were alive at a median age of 6.8 (0.6-22) years after a median follow up of 3.6 (0.1-22) years. The most frequent finding, occurring in all but 2 individuals, was liver involvement. ALF occurred only in the first year of life and was reported in 43 of 62 individuals, 11 of whom received liver transplantation. Loss-of-function TRMU variants were associated with poor survival. Supplementation with at least 1 cysteine source, typically N-acetylcysteine, improved survival significantly. Neurodevelopmental delay was observed in 11 individuals and persisted in 4 of the survivors, but we were unable to determine whether this was a primary or a secondary consequence of TRMU deficiency. Conclusion: In most patients, TRMU-associated ALF is a transient, reversible disease and cysteine supplementation improved survival